Numerous studies have shown that abnormal activation of the NF-κB signaling pathway promotes CRC proliferation, metastasis, angiogenesis, impairs the efficacy of CRC chemotherapy drugs, and facilitates CRC development. The gene discussed is NFKB1; the disease is colorectal carcinoma.